Firestoke Announce $2.2m Seed Funding Round Led by Hiro Capital to Publish Joyful Indie Games for a Global Audience
23.5.2022 16:00:00 EEST | Business Wire | Press release
Firestoke, the indie game publisher founded by serial games industry entrepreneur Paul Farley in 2021 today announced its $2.2m/£1.7m/21m kr Seed Funding round. The investment was led by Hiro Capital and includes other investors with a strong gaming and game technology pedigree, adding significant strategic value and extensive networks.
Firestoke aims to bridge the gap between a growing and increasingly diverse global audience who demand games that complement AAA and mobile experiences. Their focus on delivering compact, accessible, social and - most importantly - joyful games for console and PC is driven by a mix of creative and data driven insights.
The round was led by Hiro Capital, an entrepreneur founded venture capital fund for video games, esports, gamified fitness and Metaverse creators. Also participating in the round are Swedish games investors Behold VC and Scottish technology fund Techstart Ventures.
“It’s a privilege to have the opportunity to work with such proven game-focused investment teams at this early stage” said CEO and Founder Paul Farley. “Most importantly we value many of the same things; creating great games that bring joy and delight to players, empowering development talent and building successful businesses.”
“With this backing, in addition to our existing funding, our mission is off to a great start!”
Sir Ian Livingstone partner at Hiro Capital and games industry legend added “Hiro was built upon the premise that the UK and Europe over-index in games industry talent. Paul is no exception to this and has proven himself as an extremely capable industry veteran and operator with successful exits under his belt. We’re delighted to be backing him and the Firestoke team in their quest to champion great games from great developers.”
Firestoke will launch its first titles in late 2022 on both PC and Console platforms.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220523005568/en/
Contact information
For more information, please contact:
Bill Murphy, Team Critical Hit (Hiro Capital PR)
Email: bill@teamcriticalhit.com
Dan Gardener, Marketing Director, Firestoke
Email: dan.gardener@firestoke.games
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients30.6.2026 13:03:00 EEST | Press release
Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick's strength in commercial strategy, medical, creative, digital, analytics, and experience design, they can deliver an unparalleled scientific-to-commercial experience. “We are beyond proud to join forces with Chris, Richard, and the entire team at Oxford PharmaGenesis as we focus on helping life sciences clients think holistically about how evidence, medical strategy, access considerations, and stakeholder engagement connect across the lifecycle with a scientific-to-commercial offer
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma30.6.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating foundational BTK inhibitor BRUKINSA® (zanubrutinib) plus rituximab versus bendamustine plus rituximab (BR) in adult patients with previously untreated mantle cell lymphoma (MCL). MANGROVE is the first Phase 3, global, randomized trial to evaluate a BTK inhibitor-based chemotherapy-free regimen against standard chemoimmunotherapy in this setting. This pivotal Phase 3 trial builds on the established clinical evidence for BRUKINSA in MCL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “For patients with newly diagnosed MCL, chemotherapy is currently the default. MANGROVE demonstrates for the first time that BRUKINSA plus rituximab, a chemotherapy-free regimen, can deliver unprecedented improvements in progression-free survival, potentially redefining the
Hytera Debuts SC700 Smart 4G Body Camera at CCW 202630.6.2026 12:30:00 EEST | Press release
Hytera, a leading global provider of critical communications technologies and solutions, officially debuted its SC700 Smart 4G Body Camera at Critical Communications World (CCW) 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630283236/en/ Hytera's latest SC700 Smart 4G Body Camera Public safety operations are increasingly moving toward real-time, connected workflows, where communication, video, and situational awareness are integrated to support a faster and more coordinated response in the field. The SC700 is designed to support this shift. It enables live video, location sharing and push-to-talk communication, helping connect frontline officers with control rooms. Integrated with Hytera HyTalk PoC System, it also supports communication across broadband and PMR users to improve coordination across teams. It also features Intelligent Scene Aware, which can detect abnormal situations such as man down, inactivity, or
Global Database Launches Regis, an AI Assistant for Live Company Registry Data30.6.2026 12:13:00 EEST | Press release
Global Database today announced the launch of Regis, a new AI assistant designed to answer business questions using live company data from official government registries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630229011/en/ Unlike general-purpose AI tools that rely on training data or open web sources, Regis is connected to Global Database’s structured company intelligence platform, covering more than 600 million company profiles, sourced from over 400 government registries across more than 200 countries. For more than a decade, Global Database has been collecting, structuring, and maintaining company data directly from government registries around the world. With the launch of Regis, the company is now presenting that information in a new way: through a conversational AI assistant that allows users to ask business questions in plain English and receive structured, source-backed answers. Regis allows users to ask
Kraken Goes Live on Trever to Bring Full-Service Prime Brokerage to European Financial Institutions30.6.2026 11:30:00 EEST | Press release
Kraken Prime, the full-service prime brokerage offering trading, qualified custody and other financial services through an integrated platform, is now available through Trever, the operating standard in digital asset banking. Trever’s Digital Asset Operating System is used by financial institutions across Europe to manage the full digital asset lifecycle within a single environment – including trading, treasury, settlement and bookkeeping. From today, banks and brokers using Trever can route execution, settle into qualified custody, record all transactions and access other services through Kraken Prime without leaving their existing operational environment. The integration extends Trever’s connectivity, bringing a prime brokerage relationship into the existing workflows institutional teams use across their digital asset operations. Kraken Prime delivers institutional crypto trading across more than 20 global liquidity venues – covering over 90% of digital asset liquidity, including sma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
